These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30343985)

  • 1. Dramatic response after anti PD1 treatment failure in a squamous cell carcinoma of the maxillary sinus.
    Larroquette M; Domblides C; Cousin S; De Gabory L; Dupin C; Ravaud A; Daste A
    Oral Oncol; 2018 Dec; 87():207-209. PubMed ID: 30343985
    [No Abstract]   [Full Text] [Related]  

  • 2. A man with recurrent hypovolemic shock on anti-programmed cell death protein 1 treatment: Immune-related protein-losing enteropathy.
    Lee SY; Kim MH; Jang M; Park Y; Cho BC
    Eur J Cancer; 2018 Nov; 104():104-107. PubMed ID: 30342309
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration.
    Wang Y; Yang R; Zhao M; Guo W; Zhang L; Zhang W; Wang X
    World J Surg Oncol; 2020 May; 18(1):90. PubMed ID: 32375789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exceptional Response to PD-1 Blockade as First-Line Therapy in Head and Neck Squamous Cell Carcinoma.
    Kumai T; Komatsuda H; Minami Y; Harabuchi Y
    ORL J Otorhinolaryngol Relat Spec; 2020; 82(6):343-350. PubMed ID: 32882699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitors.
    Sukari A; Nagasaka M; Abdallah N
    Oral Oncol; 2018 May; 80():100-102. PubMed ID: 29605290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of advanced maxillary sinus squamous carcinoma: an analysis of 92 cases].
    Su YR; Wu GH; Zeng ZY; Guo ZM; Chen WK; Wei MW; Chen YF
    Ai Zheng; 2008 May; 27(5):535-8. PubMed ID: 18479606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maxillary carcinoma arising in a postoperative sinus.
    Koide C; Imai A; Yamamoto Y; Satoh Y
    Ann Otol Rhinol Laryngol; 1995 Jun; 104(6):493-5. PubMed ID: 7771725
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-treatment magnetic resonance imaging predicts outcomes of maxillary sinus cancer treatment using super-selective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy (RADPLAT).
    Yamauchi H; Baba A; Ogino N; Matsushima S; Ashida H; Nagaoka M; Ojiri H
    Auris Nasus Larynx; 2024 Aug; 51(4):631-635. PubMed ID: 38626697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frameshift events predict anti-PD-1/L1 response in head and neck cancer.
    Hanna GJ; Lizotte P; Cavanaugh M; Kuo FC; Shivdasani P; Frieden A; Chau NG; Schoenfeld JD; Lorch JH; Uppaluri R; MacConaill LE; Haddad RI
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy.
    Hwang V; Mendez E; Chow LQM; Futran ND; Andersen P; Li R; Divi V; Rodriguez CP
    Laryngoscope; 2019 Dec; 129(12):E428-E433. PubMed ID: 31074843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression beyond nivolumab: Stop or repeat? Dramatic responses with salvage chemotherapy.
    Daste A; De-Mones E; Cochin V; Dupin C; Digue L; Ravaud A; Domblides C
    Oral Oncol; 2018 Jun; 81():116-118. PubMed ID: 29703607
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
    Yasumatsu R; Nakashima T; Sato M; Nakano T; Kogo R; Hashimoto K; Sawatsubashi M; Nakagawa T
    Auris Nasus Larynx; 2017 Feb; 44(1):98-103. PubMed ID: 27108101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunocheckpoint inhibition in head and neck squamous cell carcinoma: the current status and progress].
    Huang LL; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):641-647. PubMed ID: 31550852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma metastases to the maxillary sinus.
    Wong EHC; Tetter N; Glatz K; Brand Y
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29054909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
    Weiss JM; Grilley-Olson JE; Deal AM; Zevallos JP; Chera BS; Paul J; Knowles MF; Usenko D; Weissler MC; Patel S; Hayes DN; Hackman T
    Cancer; 2018 Jul; 124(14):2986-2992. PubMed ID: 29741773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete response upon salvage chemotherapy after anti-PD1 failure: Watch and wait.
    Saleh K; Bellanger C; Garcia G; Classe M; Even C
    Eur J Cancer; 2021 Mar; 145():155-157. PubMed ID: 33476895
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune Checkpoint Inhibitor Therapy in Breast Cancer.
    Santa-Maria CA; Nanda R
    J Natl Compr Canc Netw; 2018 Oct; 16(10):1259-1268. PubMed ID: 30323094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
    Lai HC; Lin JF; Hwang TIS; Liu YF; Yang AH; Wu CK
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31058839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spindle cell sarcoma of the maxillary antrum.
    Bhaumik G; Chatterjee K
    J Indian Med Assoc; 2012 Sep; 110(9):657-8. PubMed ID: 23741844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.